NSC |
Compound |
Enrichment |
Correlation |
NSC 732336 |
[6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide |
0.00433056621075589 |
-0.21945006 |
NSC 744331 |
(2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd |
0.00433056621075589 |
0.175087 |
NSC 756169 |
GSK317314A |
0.00433056621075589 |
-0.042900476 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.00567322425730621 |
-0.18953387 |
NSC 244404 |
Null |
0.00567322425730621 |
-0.4149517 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.00567322425730621 |
-0.22509184 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.00567322425730621 |
-0.21669775 |
NSC 354974 |
Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- |
0.00567322425730621 |
0.1745078 |
NSC 363813 |
Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- |
0.00567322425730621 |
-0.047279552 |
NSC 683694 |
Null |
0.00567322425730621 |
-0.20892592 |